The authors describe that GPx-7 was overexpressed in brain, breast, esophageal, gastric, and liver cancers as well as leukemia, melanoma, myeloma, and sarcoma and underexpressed in lymphomas. This evidence concerns the gene GPX7 and sarcoma.